» Articles » PMID: 25582613

Methicillin-resistant Staphylococcus Aureus and Extended-spectrum and AmpC β-lactamase-producing Escherichia Coli in Broilers and in People Living And/or Working on Organic Broiler Farms

Overview
Journal Vet Microbiol
Date 2015 Jan 14
PMID 25582613
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to estimate the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum and AmpC β-lactamase (ESBL/AmpC)-producing Escherichia coli among broilers, and humans living and/or working on organic broiler farms; further characterise isolates; and compare these results with those from conventional farms. In the Netherlands, only 9 certified organic broiler farms were present. On 8 of these farms, 60 throat swabs and 20 cloacal swabs were taken per farm for MRSA and ESBL/AmpC-E. coli detection, respectively, at an average age of both 34 (T1) and 68 (T2) days. Faecal swabs and questionnaires were returned by 27 out of 36 humans. For selected ESBL/AmpC-producing E. coli isolates, phylogenetic groups, β-lactamase genes, plasmid families, and sequence types were determined. MRSA was not detected in broiler and human samples. ESBL/AmpC-producing E. coli were isolated from broilers on 7/8 farms at T1 and on all farms at T2. Furthermore, 3 farmers at T1, and 2 farmers and 1 family member at T2 were positive. Genes found in broilers and humans were almost exclusively blaCTX-M-1 and blaCMY-2. Given the high overall human ESBL/AmpC-prevalence (18.5%), which is similar to conventional farms, contact with live broilers is assumed a risk factor for carriage. Farm and sample-level prevalence at T1 are consistent with those from conventional farms. At T2, just before slaughter, sample-level prevalence of ESBL/AmpC-E. coli appears to have decreased (94.3% vs. 80%), which could have important consequences for contamination of retail meat.

Citing Articles

Threats across boundaries: the spread of ESBL-positive bacteria and its challenge to the "one health" concept.

Zhang S, Yang J, Abbas M, Yang Q, Li Q, Liu M Front Microbiol. 2025; 16:1496716.

PMID: 40061860 PMC: 11885248. DOI: 10.3389/fmicb.2025.1496716.


Extended-Spectrum β-Lactamases (ESBL): Challenges and Opportunities.

Husna A, Rahman M, Badruzzaman A, Sikder M, Islam M, Rahman M Biomedicines. 2023; 11(11).

PMID: 38001938 PMC: 10669213. DOI: 10.3390/biomedicines11112937.


Phylogenetic Analysis of Isolated from Australian Feedlot Cattle in Comparison to Pig Faecal and Poultry/Human Extraintestinal Isolates.

Messele Y, Trott D, Hasoon M, Veltman T, McMeniman J, Kidd S Antibiotics (Basel). 2023; 12(5).

PMID: 37237797 PMC: 10215834. DOI: 10.3390/antibiotics12050895.


The Development of Technology to Prevent, Diagnose, and Manage Antimicrobial Resistance in Healthcare-Associated Infections.

Elbehiry A, Marzouk E, Abalkhail A, El-Garawany Y, Anagreyyah S, Alnafea Y Vaccines (Basel). 2022; 10(12).

PMID: 36560510 PMC: 9780923. DOI: 10.3390/vaccines10122100.


Production systems and important antimicrobial resistant-pathogenic bacteria in poultry: a review.

Mak P, Rehman M, Kiarie E, Topp E, Diarra M J Anim Sci Biotechnol. 2022; 13(1):148.

PMID: 36514172 PMC: 9749270. DOI: 10.1186/s40104-022-00786-0.